Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
24.51
+0.28 (+1.16%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
40,101,989
Open
24.20
Bid (Size)
24.52 (15)
Ask (Size)
24.54 (28)
Prev. Close
24.23
Today's Range
24.16 - 24.53
52wk Range
20.91 - 29.36
Shares Outstanding
5,606,688,356
Dividend Yield
7.02%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
Today 2:30 EDT
From
Pfizer Inc.
Via
Business Wire
Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients
October 18, 2025
Pharma titans Merck, Pfizer and Astellas Pharma are delivering an "enormous new hope" for patients with bladder cancer.
Via
Investor's Business Daily
Performance
YTD
-7.9%
-7.9%
1 Month
+1.5%
+1.5%
3 Month
+1.0%
+1.0%
6 Month
+11.2%
+11.2%
1 Year
-16.1%
-16.1%
More News
Read More
Invo Fertility Stock Is Plunging After White House Announcement
October 17, 2025
Via
Benzinga
Pfizer CEO Urges US-China Collaboration In Pharma; Stock Drops For 7th Day As Traders Hold For Dividend Payout
October 14, 2025
Via
Stocktwits
Why Eli Lilly (LLY) Stock Is Down Today
October 17, 2025
Via
StockStory
Topics
Economy
Government
UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment
October 17, 2025
Via
Benzinga
QSM Asset Management Dumps 36,000 Whirlpool (WHR) Shares in Q3 2025
October 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs?
October 17, 2025
Via
Benzinga
Topics
Government
Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug
October 17, 2025
Via
Investor's Business Daily
ASSET PLANNING Exits Full Stake in Pfizer Worth $2.7 Million
October 16, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
AI: The Medical Maverick – Navigating Hype and Hope in Healthcare’s Digital Revolution
October 16, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
QSM Asset Management Takes $11.5 Million Stake in Rio Tinto, Expands Energy Exposure
October 16, 2025
Via
The Motley Fool
Navigating the Currents: Volatility and Growth Define U.S. Markets Amidst AI Boom and Geopolitical Headwinds
October 16, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market
October 16, 2025
Via
The Motley Fool
A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years
October 16, 2025
Via
The Motley Fool
Topics
Intellectual Property
World Trade
Why Moderna Might Be a One-Hit Wonder
October 15, 2025
Via
The Motley Fool
Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025
October 15, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Curious about the most active S&P500 stocks in today's session?
October 15, 2025
Via
Chartmill
Wall Street's Earnings Momentum Fades, Market Dips Amidst Trade Tensions
October 15, 2025
Via
MarketMinute
Topics
Economy
Supply Chain
World Trade
Pfizer CEO Reportedly Says Vaccine Approvals Getting Harder
October 15, 2025
Via
Stocktwits
Topics
Government
World Trade
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
October 15, 2025
Via
Benzinga
1 Safe-and-Steady Stock Worth Your Attention and 2 We Question
October 15, 2025
Via
StockStory
AI Revolutionizes Quality Control: A New Era of Precision and Speed in Manufacturing, Electronics, and Pharmaceuticals
October 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Fraud
Government Shutdown Casts Long Shadow Over Economy and Interest Rate Outlook Ahead of Powell's Pivotal Speech
October 14, 2025
Via
MarketMinute
Topics
Economy
Government
Regulatory Compliance
These S&P500 stocks are the most active in today's session
October 14, 2025
Via
Chartmill
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 24.51
When was Pfizer last traded?
The last trade of Pfizer was at 10/17/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 137.42B
How many shares of Pfizer are outstanding?
Pfizer has 137B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today